These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32353324)

  • 1. RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model.
    Aimiuwu OV; Fowler AM; Sah M; Teoh JJ; Kanber A; Pyne NK; Petri S; Rosenthal-Weiss C; Yang M; Harper SQ; Frankel WN
    Mol Ther; 2020 Jul; 28(7):1706-1716. PubMed ID: 32353324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Fast Synaptic Transmission in a Mouse Model of DNM1-Associated Developmental Epileptic Encephalopathy.
    McCabe MP; Shore AN; Frankel WN; Weston MC
    eNeuro; 2021; 8(2):. PubMed ID: 33372033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy.
    Asinof S; Mahaffey C; Beyer B; Frankel WN; Boumil R
    Neurobiol Dis; 2016 Nov; 95():1-11. PubMed ID: 27363778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamin-1-related infantile spasms: a case report and review of literature].
    Deng XL; Yin F; Zhang CL; Ma YP; He F; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2016 Nov; 54(11):856-859. PubMed ID: 27806796
    [No Abstract]   [Full Text] [Related]  

  • 5. Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy.
    Asinof SK; Sukoff Rizzo SJ; Buckley AR; Beyer BJ; Letts VA; Frankel WN; Boumil RM
    PLoS Genet; 2015 Jun; 11(6):e1005347. PubMed ID: 26125563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo DNM1 mutations in two cases of epileptic encephalopathy.
    Nakashima M; Kouga T; Lourenço CM; Shiina M; Goto T; Tsurusaki Y; Miyatake S; Miyake N; Saitsu H; Ogata K; Osaka H; Matsumoto N
    Epilepsia; 2016 Jan; 57(1):e18-23. PubMed ID: 26611353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A deep intronic variant in DNM1 in a patient with developmental and epileptic encephalopathy creates a splice acceptor site and affects only transcript variants including exon 10a.
    Harms FL; Weiss D; Lisfeld J; Alawi M; Kutsche K
    Neurogenetics; 2023 Jul; 24(3):171-180. PubMed ID: 37039969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-function variants in
    Yigit G; Sheffer R; Daana M; Li Y; Kaygusuz E; Mor-Shakad H; Altmüller J; Nürnberg P; Douiev L; Kaulfuss S; Burfeind P; Wollnik B; Brockmann K
    J Med Genet; 2022 Jun; 59(6):549-553. PubMed ID: 34172529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal axonal development and severe epileptic phenotype in Dynamin-1 (DNM1) encephalopathy.
    Matsubara K; Kuki I; Ishioka R; Yamada N; Fukuoka M; Inoue T; Nukui M; Okamoto N; Mizuguchi T; Matsumoto N; Okazaki S
    Epileptic Disord; 2024 Feb; 26(1):139-143. PubMed ID: 38009673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanism.
    Parthasarathy S; Ruggiero SM; Gelot A; Soardi FC; Ribeiro BFR; Pires DEV; Ascher DB; Schmitt A; Rambaud C; Represa A; Xie HM; Lusk L; Wilmarth O; McDonnell PP; Juarez OA; Grace AN; Buratti J; Mignot C; Gras D; Nava C; Pierce SR; Keren B; Kennedy BC; Pena SDJ; Helbig I; Cuddapah VA
    Am J Hum Genet; 2022 Dec; 109(12):2253-2269. PubMed ID: 36413998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.
    Afsar T; Huang X; Shah AA; Abbas S; Bano S; Mahmood A; Hu J; Razak S; Umair M
    Front Pediatr; 2023; 11():1266376. PubMed ID: 37900685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypes and phenotypes of
    Kim J; Teng LY; Shaker B; Na D; Koh HY; Kwon SS; Lee JS; Kim HD; Kang HC; Kim SH
    J Med Genet; 2023 Nov; 60(11):1076-1083. PubMed ID: 37248033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
    Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
    Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
    ; ;
    Am J Hum Genet; 2014 Oct; 95(4):360-70. PubMed ID: 25262651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and neurobehavioral abnormalities in mice with a dominant-negative KCNB1 pathogenic variant.
    Hawkins NA; Misra SN; Jurado M; Kang SK; Vierra NC; Nguyen K; Wren L; George AL; Trimmer JS; Kearney JA
    Neurobiol Dis; 2021 Jan; 147():105141. PubMed ID: 33132203
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    von Spiczak S; Helbig KL; Shinde DN; Huether R; Pendziwiat M; Lourenço C; Nunes ME; Sarco DP; Kaplan RA; Dlugos DJ; Kirsch H; Slavotinek A; Cilio MR; Cervenka MC; Cohen JS; McClellan R; Fatemi A; Yuen A; Sagawa Y; Littlejohn R; McLean SD; Hernandez-Hernandez L; Maher B; Møller RS; Palmer E; Lawson JA; Campbell CA; Joshi CN; Kolbe DL; Hollingsworth G; Neubauer BA; Muhle H; Stephani U; Scheffer IE; Pena SDJ; Sisodiya SM; Helbig I; ;
    Neurology; 2017 Jul; 89(4):385-394. PubMed ID: 28667181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy.
    Kanani F; Titheradge H; Cooper N; Elmslie F; Lees MM; Juusola J; Pisani L; McKenna C; Mignot C; Valence S; Keren B; Lachlan K; ; Balasubramanian M
    Am J Med Genet A; 2020 Apr; 182(4):713-720. PubMed ID: 31926053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
    Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
    Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Radiological, and Genetic Characterization of a Patient with a Novel Homoallelic Loss-of-Function Variant in
    AlTassan R; AlQudairy H; Alromayan R; Alfalah A; AlHarbi OA; González-Álvarez AC; Arold ST; Kaya N
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.